Biomunex Pharmaceuticals establishes US subsidiary

Biomunex Inc. to focus on R&D and business development activities in the US

29-May-2019 - USA

Biomunex Pharmaceuticals, a biopharmaceutical company focused on providing immuno-therapeutics through the discovery and development of bi- and multi-specific antibodies, announces that it has established its US subsidiary, Biomunex Pharmaceuticals Inc., in Cambridge, Massachusetts, USA.

The opening of this subsidiary is a first step in the company’s strategy to expand Biomunex’ activities in the US, with initial focus on facilitating Research & Development partnerships and business development activities with pharmaceutical companies and leading academic institutions.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance